CoChat

Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer

Open access
Bottsford-Miller, Justin, Choi, Hyun-Jin, Dalton, Heather J., Stone, Rebecca L., Cho, Min Soon, Haemmerle, Monika, Nick, Alpa M., Pradeep, Sunila, Zand, Behrouz, Previs, Rebecca A., Pecot, Chad V., Crane, Erin King, Hu, Wei, Lutgendorf, Susan K., Afshar-Kharghan, Vahid, Sood, Anil K. · 2015 · Clinical Cancer Research
Cited by 96

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Purpose: We hypothesized that platelet levels during therapy could serve as a biomarker for response to therapy and that manipulation of platelet levels could impact responsiveness to chemotherapy. Experimental Design: The medical records of patients with recurrent or progressive ovarian cancer were retrospectively queried for changes in platelet and CA-125 levels during primary therapy. In vitro coculture experiments and in vivo orthotopic models of human ovarian cancer in mice were used to test the effect of modulating platelet levels on tumor growth and responsiveness to docetaxel. Results: Thrombocytosis at the diagnosis of ovarian cancer was correlated with decreased interval to progression (P = 0.05) and median overall survival (P = 0.007). Mean platelet levels corrected during primary therapy and rose at recurrence. Contrary to treatment-responsive patients, in a cohort of patients refractory to primary therapy, platelet levels did not normalize during therapy. In A2780, HeyA8, and SKOV3-ip1 ovarian cancer cell lines, platelet coculture protected against apoptosis (P < 0.05). In orthotopic models of human ovarian cancer, platelet depletion resulted in 70% reduced mean tumor weight (P < 0.05). Compared with mice treated with docetaxel, mice treated with both docetaxel and platelet-depleting antibody had a 62% decrease in mean tumor weight (P = 0.04). Platelet transfusion increased mean aggregate tumor weight 2.4-fold (P < 0.05), blocked the effect of docetaxel on tumor growth (P = 0.55) and decreased tumor cell apoptosis. Pretransfusion aspirinization of the platelets blocked the growth-promoting effects of transfusion. Conclusions: Platelet-driven effects of chemotherapy response may explain clinical observations. Clin Cancer Res; 21(3); 602–10. ©2014 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-14-0870

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 96

Metadata

Authors
Bottsford-Miller, J., Choi, H.-J., Dalton, H. J., Stone, R. L., Cho, M. S., Haemmerle, M., Nick, A. M., Pradeep, S., Zand, B., Previs, R. A., Pecot, C. V., Crane, E. K., Hu, W., Lutgendorf, S. K., Afshar-Kharghan, V., & Sood, A. K.
Venue
Clinical Cancer Research
Published
2015-02-01
Volume
21
Issue
3
Pages
602-610
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2136996876
Cited by
96
References
5
FWCI
7.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-14-0870
The paper
Bottsford-Miller, J., Choi, H.-J., Dalton, H. J., Stone, R. L., Cho, M. S., Haemmerle, M., Nick, A. M., Pradeep, S., Zand, B., Previs, R. A., Pecot, C. V., Crane, E. K., Hu, W., Lutgendorf, S. K., Afshar-Kharghan, V., & Sood, A. K. (2015). Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-14-0870

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.